The impact of genomics on discovering drugs against infectious diseases

Microbes and Infection

Volumn 8, Issue 6, 2006, Pages 1654-1661

  Boshoff, Helena I M ^a   Manjunatha, Ujjini H ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Chemical genetics; Drug target; Genome sequencing; Systems biology

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM; ENZYME INHIBITOR; IMMUNOSUPPRESSIVE AGENT; ISONIAZID; LIPID; PENICILLIN G; PEPTIDE DEFORMYLASE INHIBITOR; PEPTIDYLTRANSFERASE; PROTEIN; PROTEIN KINASE INHIBITOR; QUINOLONE; RNA; SULFONAMIDE; TACROLIMUS;

DATA ANALYSIS; DNA METHYLATION; DRUG TARGETING; GENOMICS; HUMAN; INFECTION; METABOLITE; PHENOTYPE; PRIORITY JOURNAL; SHORT SURVEY;

ANTI-INFECTIVE AGENTS; COMMUNICABLE DISEASES; DRUG DESIGN; GENOMICS; HUMANS; PHARMACOGENETICS; SYSTEMS BIOLOGY;

EID: 33745159656     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2005.11.018     Document Type: Short Survey

References (40)

1. Andries K., Verhasselt P., Guillemont J., Gohlmann H.W., Neefs J.M., Winkler H., Van Gestel J., Timmerman P., Zhu M., Lee E., et al. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 307 (2005) 223-227
2. Lipinski C.A., Lombardo F., Dominy B.W., and Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23 (1997) 3-25
3. Kitano H. Biological robustness. Nat. Rev. Genet. 5 (2004) 826-837
4. Ma H.W., and Zeng A.P. The connectivity structure, giant strong component and centrality of metabolic networks. Bioinformatics 19 (2003) 1423-1430
5. Ramaswamy S., and Musser J.M. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis. 79 (1998) 3-29
6. Goodman M.F. Error-prone repair DNA polymerases in prokaryotes and eukaryotes. Annu. Rev. Biochem. 79 (2002) 17-50
7. Allsop A., and Illingworth R. The impact of genomics and related technologies on the search for new antibiotics. J. Appl. Microbiol. 92 (2002) 7-12
8. Karp P.D., Riley M., Saier M., Paulsen I.T., Collado-Vides J., Paley S.M., Pellegrini-Toole A., Bonavides C., and Gama-Castro S. The EcoCyc database. Nucleic Acids Res. 30 (2002) 56-58
9. Abrahamsen M.S., Templeton T.J., Enomoto S., Abrahante J.E., Zhu G., Lancto C.A., Deng M., Liu C., Widmer G., Tzipori S., et al. Complete genome sequence of the apicomplexan, Cryptosporidium parvum. Science 304 (2004) 441-445
10. Mushegian A.R., and Koonin E.V. A minimal gene set for cellular life derived by comparison of complete bacterial genomes. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 10268-10273
11. Rosamond J., and Allsop A. Harnessing the power of the genome in the search for new antibiotics. Science 287 (2000) 1973-1976
12. Roemer T., Jiang B., Davison J., Ketela T., Veillette K., Breton A., Tandia F., Linteau A., Sillaots S., Marta C., et al. Large-scale essential gene identification in Candida albicans and applications to antifungal drug discovery. Mol. Microbiol. 50 (2003) 167-181
13. Perna N.T., Plunkett III G., Burland V., Mau B., Glasner J.D., Rose D.J., Mayhew G.F., Evans P.S., Gregor J., Kirkpatrick H.A., et al. Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 409 (2001) 529-533
14. Garnier T., Eiglmeier K., Camus J.C., Medina N., Mansoor H., Pryor M., Duthoy S., Grondin S., Lacroix C., Monsempe C., et al. The complete genome sequence of Mycobacterium bovis. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 7877-7882
15. Tsolaki A.G., Hirsh A.E., DeRiemer K., Enciso J.A., Wong M.Z., Hannan M., Hannan M., de la Salmoniere Y.O.G., Aman K., Kato-Maeda M., and Small P.M. Functional and evolutionary genomics of Mycobacterium tuberculosis: insights from genomic deletions in 100 strains. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 4865-4870
16. Price N.D., Reed J.L., and Palsson B.O. Genome-scale models of microbial cells: evaluating the consequences of constraints. Nat. Rev. Microbiol. 2 (2004) 886-897
17. Bakker B.M., Westerhoff H.V., Opperdoes F.R., and Michels P.A. Metabolic control analysis of glycolysis in trypanosomes as an approach to improve selectivity and effectiveness of drugs. Mol. Biochem. Parasitol 106 (2000) 1-10
18. Hayes F. Transposon-based strategies for microbial functional genomics and proteomics. Annu. Rev. Genet. 37 (2003) 3-29
19. Yin D., Fox B., Lonetto M.L., Etherton M.R., Payne D.J., Holmes D.J., Rosenberg M., and Ji Y. Identification of antimicrobial targets using a comprehensive genomic approach. Pharmacogenomics 5 (2004) 101-113
20. Knuth K., Niesalla H., Hueck C.J., and Fuchs T.M. Large-scale identification of essential Salmonella genes by trapping lethal insertions. Mol. Microbiol. 51 (2004) 1729-1744
21. Liu J., Dehbi M., Moeck G., Arhin F., Bauda P., Bergeron D., Callejo M., Ferretti V., Ha N., Kwan T., et al. Antimicrobial drug discovery through bacteriophage genomics. Nat. Biotechnol. 22 (2004) 185-191
22. Waller A.S., and Clements J.M. Novel approaches to antimicrobial therapy: peptide deformylase. Curr. Opin. Drug Discov. Devel. 5 (2002) 785-792
23. Marra A. Can virulence factors be viable antibacterial targets?. Expert Rev. Anti. Infect. Ther. 2 (2004) 61-72
24. Hentzer M., Wu H., Andersen J.B., Riedel K., Rasmussen T.B., Bagge N., Kumar N., Schembri M.A., Song Z., Kristoffersen P., et al. Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. Embo. J. 22 (2003) 3803-3815
25. Boshoff H.I., Myers T.G., Copp B.R., McNeil M.R., Wilson M.A., and Barry III C.E. The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action. J. Biol. Chem. 279 (2004) 40174-40184
26. Stoughton R.B. Applications of DNA Microarrays in Biology. Annu. Rev. Biochem. (2004)
27. Hutter B., Schaab C., Albrecht S., Borgmann M., Brunner N.A., Freiberg C., Ziegelbauer K., Rock C.O., Ivanov I., and Loferer H. Prediction of mechanisms of action of antibacterial compounds by gene expression profiling. Antimicrob. Agents Chemother. 48 (2004) 2838-2844
28. Hughes T.R., Marton M.J., Jones A.R., Roberts C.J., Stoughton R., Armour C.D., Bennett H.A., Coffey E., Dai H., He Y.D., et al. Functional discovery via a compendium of expression profiles. Cell 102 (2000) 109-126
29. Chua G., Robinson M.D., Morris Q., and Hughes T.R. Transcriptional networks: reverse-engineering gene regulation on a global scale. Curr. Opin. Microbiol. 7 (2004) 638-646
30. Butcher P.D. Microarrays for Mycobacterium tuberculosis. Tuberculosis 84 (2004) 131-137 (Edinb)
31. Hecker M., and Volker U. Towards a comprehensive understanding of Bacillus subtilis cell physiology by physiological proteomics. Proteomics 4 (2004) 3727-3750
32. Xia Y., Yu H., Jansen R., Seringhaus M., Baxter S., Greenbaum D., Zhao H., and Gerstein M. Analyzing cellular biochemistry in terms of molecular networks. Annu. Rev. Biochem. 73 (2004) 1051-1087
33. Mawuenyega K.G., Forst C.V., Dobos K.M., Belisle J.T., Chen J., Bradbury E.M., Bradbury A.R., and Chen X. Mycobacterium tuberculosis functional network analysis by global subcellular protein profiling. Mol. Biol. Cell 16 (2005) 396-404
34. Arkin M.R., and Wells J.A. Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat. Rev. Drug Discov. 3 (2004) 301-317
35. Mitsopoulos G., Walsh D.P., and Chang Y.T. Tagged library approach to chemical genomics and proteomics. Curr. Opin. Chem. Biol. 8 (2004) 26-32
36. Shim J.S., and Kwon H.J. Chemical genetics for therapeutic target mining. Expert. Opin. Ther. Targets 8 (2004) 653-661
37. Lewis L.M., Engle L.J., Pierceall W.E., Hughes D.E., and Shaw K.J. Affinity capillary electrophoresis for the screening of novel antimicrobial targets. J. Biomol. Screen 9 (2004) 303-308
38. Walsh D.P., and Chang Y.T. Recent advances in small molecule microarrays: applications and technology. Comb. Chem. High Throughput Screen 7 (2004) 557-564
39. Bailey S.N., Sabatini D.M., and Stockwell B.R. Microarrays of small molecules embedded in biodegradable polymers for use in mammalian cell-based screens. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 16144-16149
40. Annis D.A., Athanasopoulos J., Curran P.J., Felsch J.S., Kalghatgi K., Lee W.H., Nash H.M., Orminati J.-P.A., and Rosner K.E. An affinity selection-mass spectrometry method for the identification of small molecule ligands from self-encoded combinatorial libraries: discovery of a novel antagonist of E. coli dihydrofolate reductase. Int. J. Mass Spectrom. 238 (2004) 77-83